Neovascularization and cardiac repair by bone marrow-derived stem cells
Related Experiment Video
Updated: Aug 14, 2026
Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
1Department of Molecular Cardiology, University of Frankfurt, Theodor Stern-Kai 7, 60590 Frankfurt, Germany.
Insights
Adult stem cells show potential for cardiac regeneration after heart attack. These cells may form new heart muscle cells or blood vessels, aiding recovery in patients with coronary artery disease.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Stem Cell Therapy
Background:
- Postinfarction congestive heart failure involves cardiomyocyte loss and impaired systolic function.
- Adult stem and progenitor cells can differentiate into endothelial cells and cardiomyocytes.
- Autologous stem cell therapy is a promising strategy for cardiac regeneration.
Purpose of the Study:
- To review experimental data on neovascularization and cardiomyocyte formation from adult stem/progenitor cells.
- To discuss the potential of cell therapy for cardiac repair post-myocardial infarction.
Main Methods:
- Review of experimental studies on adult stem/progenitor cell differentiation.
- Analysis of data on cell therapy in postinfarction patients.
Main Results:
- Adult stem/progenitor cells can differentiate into cardiomyocytes and endothelial cells.
- Cell therapy has shown benefits in pilot clinical trials for coronary artery disease.
- Paracrine factors released by cells contribute to neovascularization and scar remodeling.
Conclusions:
- Adult stem/progenitor cells offer a promising therapeutic approach for cardiac regeneration.
- Cell therapy may restore cardiac function through cell replacement and neovascularization.
- Further research is warranted to optimize stem cell therapy for heart failure.
Abstract:
Postinfarction congestive heart failure with impaired systolic left ventricular function is a loss of cardiomyocyte disease. Adult stem or progenitor cells from the bone marrow and the peripheral blood have been experimentally shown to differentiate towards endothelial cells and cardiomyocytes under the appropriate conditions. The use of autologous adult stem cells for neovascularization and cardiac regeneration is a promising concept and has shown benefit in pilot clinical trails enrolling postinfarction patients with coronary artery disease. Cell therapy may act through differentiation into and thus replacement of cardiomyocytes and/or neovascularization, the formation of new vessels in the adult organism. Moreover, the release of factors acting in a paracrine manner may contribute to neovascularization and scar remodelling. In this review, the experimental data regarding neovascularization and cardiomyocyte formation from adult stem/progenitor cells are discussed.
